Citation notice #9504 · 2026-08-11 00:18:03.633065+00:00

Visualisation of multi-indication randomised control trial evidence to support decision-making in oncology: a case study on bevacizumab

Correction Crossref Open

cites 10.1200/jco.2015.61.5005, which carries a correction notice dated 2016-08-24. One-hop deterministic notice: the citation edge exists in the Pith bibliography graph; no model judged whether the citation was load-bearing.

This is not a judgment on the citing paper.

Citing paper Event page Original DOI Notice DOI File a formal challenge All reference changes

01Evidence

Raw extraction · bibliography line · bibliography index 32

Sandmann T, Bourgon R, Garcia J, et al. Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: Retrospective analysis of the A V Aglio trial. J Clin Oncol 2015; 33: 2735-2744. 20150629. DOI: 10.1200/jco.2015.61.5005

02Event

Type: Correction
Source: Crossref
Original DOI: 10.1200/jco.2015.61.5005
Notice DOI: 10.1200/jco.2016.69.6674
Date: 2016-08-24
Title: ERRATUM
Reasons: ['Correction']
Work: - (2015)

Schema constants (for re-runners): correction · crossref

03Dispute this notice

If this citation does not depend on the flagged claim, or the event is wrong, say so. Disputes are public. For a signed challenge against the paper itself, use the formal challenge form.